Vaccine development – Page 70 – Communicable Diseases Research

Addressing COVID‐19 Drug Development with Artificial Intelligence

Essay

Published on 2020-04-272022-10-28
Journal: Advanced Intelligent Systems (Weinheim an Der Bergstrasse, Germany) [Category] COVID-19,

[키워드] acute respiratory syndrome antibodies antibody approach approaches artificial artificial intelligence cause clinical trial Combination combination therapies combination therapy composed coronavirus COVID-19 COVID‐19 development drug drug combination Drug development Drug screening Efficacy effort ENhance evaluated Healthcare system identify Inc include Infectious disease intelligence Moderna Multiple outcomes pandemic pathogen Phase I regimen repurposed therapies SARS‐CoV‐2 severe acute respiratory syndrome coronavirus 2 sustained therapy timeline Treatment turn Vaccine Vaccine development Vaccines virus widespread
[DOI] 10.1002/aisy.202000070 PMC 바로가기 [Article Type] Essay

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment

Brief Report

Published on 2020-04-262022-10-28
Journal: Pathogens [Category] COVID-19,

Cross-Protection Induced by Encephalitis Vaccines against COVID-19 Might be a Reason for Relatively Lower Mortality Rate in Some Countries

Letter to Editor

Published on 2020-04-212022-10-27
Journal: Archives of Academic Emergency Medicine [Category] COVID-19,

Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions

Minireview

Published on 2020-04-192022-10-31
Journal: Experimental Biology and Medicine [Category] COVID-19, SARS,

In silico identification of vaccine targets for 2019-nCoV

Research Article

Published on 2020-04-142022-10-31
Journal: F1000Research [Category] COVID-19, MERS, SARS,

Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity

Short communication

Published on 2020-04-092022-10-30
Journal: Journal of Translational Autoimmunity [Category] COVID-19,

[키워드] adaptive immune system Antigen Antigen presentation Autoantigens Autoimmunity Bacteria candidate class consequence contribute COVID-19 COVID-19 disease Critical element epitope excluded expected explain exposure failure genes encoding had no homologous homology human protein human proteins Immune Enhancement immune system immunogenic immunological priming Immunopathogenesis in viral indicate Infection injection involved Local lung tissue mapping MERS MERS spike protein MHC Mortality outcomes Pathogenesis pathogenic Pathogenic priming pathway peptide priming Protein provide responsible risk SAR-CoV-2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 protein SARS-CoV-2 proteins Signaling similarity Spike proteins Symptom target Trial vaccination Vaccine Vaccine development Viral protein virus
[DOI] 10.1016/j.jtauto.2020.100051 PMC 바로가기 [Article Type] Short communication

Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind

Commentary

Published on 2020-04-072022-10-29
Journal: Infectious Diseases of Poverty [Category] COVID-19, SARS,

Progress and Prospects on Vaccine Development against SARS-CoV-2

Review

Published on 2020-03-292022-10-28
Journal: Vaccines [Category] COVID-19,

Functional Annotation and Curation of Hypothetical Proteins Present in A Newly Emerged Serotype 1c of Shigella flexneri : Emphasis on Selecting Targets for Virulence and Vaccine Design Studies

신규 출현한 Shigella flexneri의 세로타입 1c에 존재하는 가설 단백질의 기능 주석 및 큐레이션: 병원성과 백신 설계 연구를 위한 표적 선택 강조

Article

Published on 2020-03-232024-07-30
Journal: Genes [Category] 세균성이질,

[키워드] functional elucidation hypothetical proteins protein function Shigella flexneri Vaccine development virulence
[DOI] 10.3390/genes11030340 PMC 바로가기 [Article Type] Article

SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far

Review

Published on 2020-03-202022-10-28
Journal: Pathogens [Category] COVID-19,